Recent advances in neuroendovascular therapy

Clinical Neurology and Neurosurgery

Volumn 115, Issue 7, 2013, Pages 853-858

  Duffis, E Jesús ^a,b   Tank, Vivek ^a   Gandhi, Chirag D ^a,b   Prestigiacomo, Charles J ^a,b  

^a New Jersey Medical School   (United States)

^b RUTGERS NEW JERSEY MEDICAL SCHOOL   (United States)

Author keywords

Aneurysm; Endovascular; Stroke; Treatment

Indexed keywords

BRAIN ARTERY ANEURYSM; BRAIN ATHEROSCLEROSIS; BRAIN ISCHEMIA; CAROTID ARTERY STENTING; CAROTID ATHEROSCLEROSIS; CAROTID ENDARTERECTOMY; DEVICE THERAPY; ENDOVASCULAR SURGERY; HUMAN; MECHANICAL THROMBECTOMY; PERCUTANEOUS TRANSLUMINAL ANGIOPLASTY; REVIEW;

ENDOVASCULAR PROCEDURES; HUMANS; INTRACRANIAL ARTERIOSCLEROSIS; NEUROSURGICAL PROCEDURES; STENTS; STROKE; THROMBECTOMY;

EID: 84878840346     PISSN: 03038467     EISSN: 18726968     Source Type: Journal    
DOI: 10.1016/j.clineuro.2013.01.015     Document Type: Review

References (47)

1. V.L. Roger, A.S. Go, D.M. Lloyd-Jones, E.J. Benjamin, J.D. Berry, and W.B. Borden Heart disease and stroke statistics-2012 update: a report from the American Heart Association Circulation 125 1 2012 e2 e220
2. First ed: Cambridge University Press.
3. H.J. Barnett, M. Eliasziw, H.E. Meldrum, and D.W. Taylor Do the facts and figures warrant a 10-fold increase in the performance of carotid endarterectomy on asymptomatic patients? Neurology 46 3 1996 603 608
4. Beneficial effect of carotid endarterectomy in symptomatic patients with high-grade carotid stenosis. North American Symptomatic Carotid Endarterectomy Trial Collaborators New England Journal of Medicine 325 7 1991 445 453
5. Endarterectomy for asymptomatic carotid artery stenosis. Executive Committee for the Asymptomatic Carotid Atherosclerosis Study JAMA 273 18 1995 1421 1428
6. Randomised trial of endarterectomy for recently symptomatic carotid stenosis: final results of the MRC European Carotid Surgery Trial (ECST) Lancet 351 9113 1998 1379 1387
7. A. Halliday, A. Mansfield, J. Marro, C. Peto, R. Peto, and J. Potter Prevention of disabling and fatal strokes by successful carotid endarterectomy in patients without recent neurological symptoms: randomised controlled trial Lancet 363 9420 2004 1491 1502
8. J.L. Mas, G. Chatellier, B. Beyssen, A. Branchereau, T. Moulin, and J.P. Becquemin Endarterectomy versus stenting in patients with symptomatic severe carotid stenosis New England Journal of Medicine 355 16 2006 1660 1671
9. J. Ederle, J. Dobson, R.L. Featherstone, L.H. Bonati, H.B. van der Worp, and G.J. de Borst Carotid artery stenting compared with endarterectomy in patients with symptomatic carotid stenosis (International Carotid Stenting Study): an interim analysis of a randomised controlled trial Lancet 375 9719 2010 985 997
10. SPACE Collaborative Group P.A. Ringleb, J. Allenberg, H. Brückmann, H.H. Eckstein, and G. Fraedrich 30 day results from the SPACE trial of stent-protected angioplasty versus carotid endarterectomy in symptomatic patients: a randomised non-inferiority trial Lancet 368 9543 2006 1239 1247
11. T.G. Brott, R.W. Hobson 2nd, G. Howard, G.S. Roubin, W.M. Clark, and W. Brooks Stenting versus endarterectomy for treatment of carotid-artery stenosis New England Journal of Medicine 363 1 2010 11 23
12. S. Chaturvedi, J.S. Matsumura, W. Gray, C. Xu, P. Verta, and CAPTURE 2 Investigators and Executive Committee Carotid artery stenting in octogenarians: periprocedural stroke risk predictor analysis from the multicenter Carotid ACCULINK/ACCUNET Post Approval Trial to Uncover Rare Events (CAPTURE 2) clinical trial Stroke 41 4 2010 757 764
13. R.J. Wityk, D. Lehman, M. Klag, J. Coresh, H. Ahn, and B. Litt Race and sex differences in the distribution of cerebral atherosclerosis Stroke 27 11 1996 1974 1980
14. D. Inzitari, V.C. Hachinski, D.W. Taylor, and H.J. Barnett Racial differences in the anterior circulation in cerebrovascular disease. How much can be explained by risk factors? Archives of Neurology 47 10 1990 1080 1084
15. S.E. Kasner, M.I. Chimowitz, M.J. Lynn, H. Howlett-Smith, B.J. Stern, and V.S. Hertzberg Predictors of ischemic stroke in the territory of a symptomatic intracranial arterial stenosis Circulation 113 4 2006 555 563
16. M.I. Chimowitz, M.J. Lynn, C.P. Derdeyn, T.N. Turan, D. Fiorella, and B.F. Lane Stenting versus aggressive medical therapy for intracranial arterial stenosis New England Journal of Medicine 365 11 2011 993 1003
17. O.O. Zaidat, R. Klucznik, M.J. Alexander, J. Chaloupka, H. Lutsep, and S. Barnwell The NIH registry on use of the Wingspan stent for symptomatic 70-99% intracranial arterial stenosis Neurology 70 17 2008 1518 1524
18. J.H. Rha, and J.L. Saver The impact of recanalization on ischemic stroke outcome: a meta-analysis Stroke 38 3 2007 967 973
19. J.D. Fields, H.L. Lutsep, W.S. Smith, and MERCI Multi MERCI Investigators Higher degrees of recanalization after mechanical thrombectomy for acute stroke are associated with improved outcome and decreased mortality: pooled analysis of the MERCI and Multi MERCI trials American Journal of Neuroradiology 32 11 2011 2170 2174
20. A.C. Flint, G.R. Duckwiler, R.F. Budzik, D.S. Liebeskind, W.S. Smith, and MERCI and Multi MERCI Writing Committee Mechanical thrombectomy of intracranial internal carotid occlusion: pooled results of the MERCI and Multi MERCI Part I trials Stroke 38 4 2007 1274 1280
21. M. Saqqur, K. Uchino, A.M. Demchuk, C.A. Molina, Z. Garami, and S. Calleja Site of arterial occlusion identified by transcranial Doppler predicts the response to intravenous thrombolysis for stroke Stroke 38 3 2007 948 954
22. I. Linfante, R.H. Llinas, M. Selim, C. Chaves, S. Kumar, and R.A. Parker Clinical and vascular outcome in internal carotid artery versus middle cerebral artery occlusions after intravenous tissue plasminogen activator Stroke 33 8 2002 2066 2071
23. M.T. Wunderlich, M. Goertler, T. Postert, E. Schmitt, G. Seidel, and G. Gahn Recanalization after intravenous thrombolysis: does a recanalization time window exist? Neurology 68 17 2007 1364 1368
24. O. Adeoye, R. Hornung, P. Khatri, and D. Kleindorfer Recombinant tissue-type plasminogen activator use for ischemic stroke in the United States: a doubling of treatment rates over the course of 5 years Stroke 42 7 2011 1952 1955
25. D. Kleindorfer, C.J. Lindsell, L. Brass, W. Koroshetz, and J.P. Broderick National US estimates of recombinant tissue plasminogen activator use: ICD-9 codes substantially underestimate Stroke 39 3 2008 924 928
26. E.A. Noser, H.M. Shaltoni, C.E. Hall, A.V. Alexandrov, Z. Garami, and E.D. Cacayorin Aggressive mechanical clot disruption: a safe adjunct to thrombolytic therapy in acute stroke? Stroke 36 2 2005 292 296
27. T. Pfefferkorn, T.E. Mayer, C. Opherk, N. Peters, A. Straube, and H.W. Pfister Staged escalation therapy in acute basilar artery occlusion: intravenous thrombolysis and on-demand consecutive endovascular mechanical thrombectomy: preliminary experience in 16 patients Stroke 39 5 2008 1496 1500
28. Z.S. Shi, Y. Loh, G. Walker, and G.R. Duckwiler Endovascular thrombectomy for acute ischemic stroke in failed intravenous tissue plasminogen activator versus non-intravenous tissue plasminogen activator patients: revascularization and outcomes stratified by the site of arterial occlusions Stroke 41 6 2010 1185 1192
29. Penumbra Pivotal Stroke Trial Investigators The penumbra pivotal stroke trial: safety and effectiveness of a new generation of mechanical devices for clot removal in intracranial large vessel occlusive disease Stroke 40 8 2009 2761 2768
30. R. Tarr, D. Hsu, Z. Kulcsar, C. Bonvin, D. Rufenacht, and K. Alfke The POST trial: initial post-market experience of the Penumbra system: revascularization of large vessel occlusion in acute ischemic stroke in the United States and Europe Journal of NeuroInterventional Surgery 2 4 2010 341 344
31. W.S. Smith, G. Sung, J. Saver, R. Budzik, G. Duckwiler, and D.S. Liebeskind Mechanical thrombectomy for acute ischemic stroke: final results of the Multi MERCI trial Stroke 39 4 2008 1205 1212
32. J.L. Saver, R. Jahan, E.I. Levy, T.G. Jovin, B. Baxter, and R.G. Nogueira Solitaire flow restoration device versus the Merci Retriever in patients with acute ischaemic stroke (SWIFT): a randomised, parallel-group, non-inferiority trial The Lancet 380 9849 2012 1241 1249
33. R.G. Nogueira, H.L. Lutsep, R. Gupta, T.G. Jovin, G.W. Albers, and G.A. Walker Trevo versus Merci retrievers for thrombectomy revascularisation of large vessel occlusions in acute ischaemic stroke (TREVO 2): a randomised trial The Lancet 380 2012 1231 1240
34. L. San Román, V. Obach, J. Blasco, J. Macho, A. Lopez, and X. Urra Single-center experience of cerebral artery thrombectomy using the TREVO device in 60 patients with acute ischemic stroke Stroke 43 6 2012 1657 1659
35. A.J. Molyneux, R.S. Kerr, L.M. Yu, M. Clarke, M. Sneade, and J.A. Yarnold International subarachnoid aneurysm trial (ISAT) of neurosurgical clipping versus endovascular coiling in 2143 patients with ruptured intracranial aneurysms: a randomised comparison of effects on survival, dependency, seizures, rebleeding, subgroups, and aneurysm occlusion Lancet 366 9488 2005 809 817
36. P.K. Nelson, P. Lylyk, I. Szikora, S.G. Wetzel, I. Wanke, and D. Fiorella The pipeline embolization device for the intracranial treatment of aneurysms trial American Journal of Neuroradiology 32 1 2011 34 40
37. D.F. Kallmes, Y.H. Ding, D. Dai, R. Kadirvel, D.A. Lewis, and H.J. Cloft A new endoluminal, flow-disrupting device for treatment of saccular aneurysms Stroke 38 8 2007 2346 2352
38. P. Lylyk, C. Miranda, R. Ceratto, A. Ferrario, E. Scrivano, and H.R. Luna Curative endovascular reconstruction of cerebral aneurysms with the pipeline embolization device: the Buenos Aires experience Neurosurgery 64 4 2009 632 642 [discussion 642-3; quiz N6]
39. I. Szikora, Z. Berentei, Z. Kulcsar, M. Marosfoi, Z.S. Vajda, and W. Lee Treatment of intracranial aneurysms by functional reconstruction of the parent artery: the Budapest experience with the pipeline embolization device American Journal of Neuroradiology 31 6 2010 1139 1147
40. Available from: http://www.ev3.net/neuro/intl/flow-diversion/ embolization-device-product.htm.
41. S. Pistocchi, R. Blanc, B. Bartolini, and M. Piotin Flow diverters at and beyond the level of the circle of willis for the treatment of intracranial aneurysms Stroke 43 4 2012 1032 1038
42. W. McAuliffe, V. Wycoco, H. Rice, C. Phatouros, T.J. Singh, and J. Wenderoth Immediate and midterm results following treatment of unruptured intracranial aneurysms with the pipeline embolization device American Journal of Neuroradiology 33 1 2012 164 170
43. A.J. Molyneux, S. Cekirge, I. Saatci, and G. Gál Cerebral Aneurysm Multicenter European Onyx (CAMEO) trial: results of a prospective observational study in 20 European centers American Journal of Neuroradiology 25 1 2004 39 51
44. R.L. Piske, L.H. Kanashiro, E. Paschoal, C. Agner, S.S. Lima, and P.H. Aguiar Evaluation of Onyx HD-500 embolic system in the treatment of 84 wide-neck intracranial aneurysms Neurosurgery 64 5 2009 E865 E875 [discussion E875]
45. S.D. Simon, E. Eskioglu, A. Reig, and R.A. Mericle Endovascular treatment of side wall aneurysms using a liquid embolic agent: a US single-center prospective trial Neurosurgery 67 3 2010 855 860 [discussion 860]
46. W. Weber, R. Siekmann, B. Kis, and D. Kuehne Treatment and follow-up of 22 unruptured wide-necked intracranial aneurysms of the internal carotid artery with Onyx HD 500 American Journal of Neuroradiology 26 8 2005 1909 1915
47. R.T. Dalyai, C. Randazzo, G. Ghobrial, L.F. Gonzalez, S.I. Tjoumakaris, and A.S. Dumont Redefining Onyx HD 500 in the flow diversion era International Journal of Vascular Medicine 2012 2012 435490